RxDoctor Payments Data

Gabrielle Crawford

Family · Lynchburg, VANPI 1447631189

Payments from drug & device makers

$1,284in general payments, 2019–2025

Across 15 payments — averaging $85.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$295
  • Novo Nordisk$176
  • Silk Road Medical, Inc.$148
  • Phathom Pharmaceuticals, Inc.$113
  • Amgen$109
  • Neurocrine Biosciences, Inc.$106
  • plus $337 from 5 others

What the payments were for

  • Speaking & faculty fees$151%
  • Food & beverage$1,26999%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie4$295
Novo Nordisk2$176
Silk Road Medical, Inc.1$148
Phathom Pharmaceuticals, Inc.1$113
Amgen1$109
Neurocrine Biosciences, Inc.1$106
AstraZeneca1$104
Dexcom, Inc.1$93
SK Life Science, Inc.1$88
Abbott1$36
Mckesson Medical-surgical, Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,284 in reported general payments places this provider in the 75th percentile of 4,332 family providers in Virginia.

See all family providers in Virginia

Medicare billing

Part B allowed, 2024
$4,156
Medicare patients
54
Services billed
66

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl17$36
Tramadol Hcl11$20

Paid to pharmacies, not to this prescriber.

Other family in Lynchburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →